English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Dec 10, 2025

Cedars-Sinai develops experimental RNA drug for DNA repair and tissue healing

+ Pharmaceuticals
Patient Daily | Dec 10, 2025

Bliksem Health founder: Independent physicians are being 'out-regulated and out-subsidized’ under 340B

+ Pharmaceuticals
Patient Daily | Dec 10, 2025

American Lung Association funds early career researchers through Catalyst Award

+ Pharmaceuticals
Patient Daily | Dec 10, 2025

Japanese pharma companies increase global M&A activity amid changing strategies

+ Pharmaceuticals
Patient Daily | Dec 10, 2025

Tooth decay among English adults returns to rates last seen in late 1990s

+ Pharmaceuticals
Patient Daily | Dec 10, 2025

Most Arizona voters support expanding clean energy projects over new gas plants

+ Pharmaceuticals
Patient Daily | Dec 9, 2025

Top five VC raises highlight trends among women-founded biopharmas

+ Pharmaceuticals
Patient Daily | Dec 9, 2025

APIC and SHEA create advisory group after CDC committee disbanded

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 203
  • 204
  • 205
  • 206
  • 207
  • 208
  • 209
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily